F16.24 Hallucinogen dependence with hallucinogen-induced mood disorder

The ICD-10-CM code for Hallucinogen dependence with hallucinogen-induced mood disorder is F16.24 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Chapter

5: Mental, Behavioral and Neurodevelopmental disorders (F01-F99)

Section

F10-F19: Mental and behavioral disorders due to psychoactive substance use (F10-F19)

Category F16

53 codes (40 billable)

FY2026 Status

Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to F16.24:

• Dependence (on) (syndrome) › drug NEC › hallucinogen › with › mood disorder
• Disorder (of) › hallucinogen use › moderate or severe › with › hallucinogen-induced › bipolar and related disorder
• Disorder (of) › hallucinogen use › moderate or severe › with › hallucinogen-induced › depressive disorder
• Disorder (of) › phencyclidine use › moderate or severe › with › phencyclidine-induced › depressive disorder
• Disorder (of) › phencyclidine use › moderate or severe › with › phencyclidine-induced › bipolar and related disorder
• Disorder (of) › mood › due to (secondary to) › hallucinogen › in › dependence
• Disorder (of) › mood › due to (secondary to) › phencyclidine (PCP) › in › dependence

Inclusion Terms

• Other hallucinogen use disorder, moderate, with other hallucinogen induced bipolar or related disorder
• Other hallucinogen use disorder, moderate, with other hallucinogen induced depressive disorder
• Other hallucinogen use disorder, severe, with other hallucinogen-induced bipolar or related disorder
• Other hallucinogen use disorder, severe, with other hallucinogen-induced depressive disorder
• Phencyclidine use disorder, moderate, with phencyclidine induced bipolar or related disorder
• Phencyclidine use disorder, moderate, with phencyclidine induced depressive disorder
• Phencyclidine use disorder, severe, with phencyclidine induced bipolar or related disorder
• Phencyclidine use disorder, severe, with phencyclidine-induced depressive disorder

U.S. Hospital Utilization

• An estimated 70 U.S. inpatient stays in 2023 included F16.24 among the documented diagnoses.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Pain disorders related to psychological factors (TOC entry)

a. Pain disorders related to psychological factors ..................................................................... 43

Psychoactive substance use disorders (TOC entry)

b. Mental and behavioral disorders due to psychoactive substance use ................................... 43

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

• CMS — ICD-10-CM Official Code Set and Guidelines, FY2026
• CDC/NCHS — ICD-10-CM Files and Browser Tool
• AHRQ — HCUP National Inpatient Sample, Frequencies by Diagnosis Code (2016–2023)